During the 2010-11 surveillance season, the New Vaccine Surveillance Network identified an RVA strain, RVA/ human-wt/USA/2011729115/2011/G2P [4] (2011729115), which also contained a vaccine-derived NSP2 gene. This specimen was obtained from a 4-year-old child through routine active surveillance in the emergency department at Texas Children's Hospital (Houston, TX, USA). RVA double-stranded RNA was extracted from a fecal sample from the child by using Trizol reagent (Life Technologies, Grand Island, NY, USA). The sequencing templates were prepared by using sequence-independent whole-genome reverse transcription PCR amplification (7) with slight modifications. PCR amplicons were sequenced by the Illumina Miseq 150 paired-end method at the Genomics Laboratory, Hudson Alpha Institute for Biotechnology (Huntsville, AL, USA). Illumina sequence reads were analyzed by using CLC Genomics Workbench 6.0.
(http://www.clcbio.com/products/clc-genomics-workbench/). A combination of de novo assembly followed by mapping to a G2P [4] reference strain was used to obtain the full-length genome of strain 2011729115. The sequences were submitted to GenBank under accession nos. KR701624-KR701634. Genotype assignment for each gene was performed by using a combination of BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi) and RotaC 2.0 (http://rotac.regatools.be/). For each gene, multiple alignments were made by using the MUSCLE algorithm implemented in MEGA 5.1 (8) . Maximum-likelihood trees were constructed for each gene in PhyML 3.0 (http://www. atgc-montpellier.fr/phyml/) by using the optimal model for each alignment as identified by jModeltest 2 (TrN+I) and approximate-likelihood ratio test (aLRT) statistics computed for branch support (9, 10) .
The full genotype constellation for strain 2011729115 is G2-P[4]-I2-R2-C2-M2-A2-N2-T2-E2-H2, which is a DS-1 like constellation. The G2P [4] strains from the 2010-11 season shared 97.6%-100% nt identity for the NSP2 gene, except for strain 2011729115, which exhibited only 86.8%-87.3% nt identity with the other circulating G2P [4] strains. BLAST analysis of sequences deposited in GenBank indicated that the 2011729115 NSP2 gene was 100% identical to published RotaTeq NSP2 gene sequences and clustered with the 5 RotaTeq NSP2 sequences in phylogenetic analysis (Figure) . The NSP2 protein functions as a single-stranded RNA binding protein, nucleic acid helix destabilizer, nucleoside triphosphatase (NTP), nucleoside diphosphate kinase (NDP), and RNA triphosphatase (RTPase) (2) . No amino acid differences in the RNA binding and NDP/NTP/RTPase domains were found between the NSP2 gene from strain 2011729115 and the G2P [4] strains (data not shown), suggesting that this vaccine-derived NSP2 protein can function like the wild-type version.
In conclusion, we identified an NSP2 gene RotaTeq reassortant in an RVA with a DS-1 like genotype. Although the child from whom the NSP2 reassortment specimen was obtained had been vaccinated with a complete regimen of 3 doses of RotaTeq in 2007, no other RotaTeq genes could be detected in the fecal sample. This finding could suggest a reassortment event and infection independent of the vaccination in 2007, although precisely where this reassortment event took place is difficult to ascertain. The existence of a viable NSP2 wild-type reassortant was also proposed by Bucardo et al. (6) . Whether the RotaTeq NSP2 gene provides any fitness advantage to the virus during infection of vaccinated children also is unclear; during the 2010-11 season, other cases of G2P [4] -associated gastroenteritis in vaccinated children, in which the RotaTeq NSP2 gene was lacking, were reported. Our finding of strain RVA/humanwt/USA/2011729115/2011/G2P [4] , a wild-type RVA with a vaccine-derived NSP2 gene, in a child with acute gastroenteritis in the United States highlights the need for continued rotavirus surveillance, domestically and internationally, after vaccine introduction. 
